Valion Bio (VBIO) Net Shares Issued and Repurchased (2021 - 2025)

Valion Bio has reported Net Shares Issued and Repurchased for 5 years, with the latest figure at $400500.0 in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 4833.48% year-over-year to $400500.0 in Q4 2025; TTM through Dec 2025 was $400500.0, a 4833.48% increase from a year earlier, with the FY2025 full-year figure at $400500.0, up 4833.48% from the prior year.
• Net Shares Issued and Repurchased was $400500.0 for Q4 2025 at Valion Bio, up from $8118.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $443750.0 in Q1 2022, with the low at $339.0 in Q4 2023.
• Average Net Shares Issued and Repurchased over 5 years is $153415.5, with a median of $43500.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased slumped 97.37% in 2022, then soared 4833.48% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $280250.0 in 2021, then plunged by 97.37% to $7367.0 in 2022, then plunged by 95.4% to $339.0 in 2023, then surged by 2294.69% to $8118.0 in 2024, then jumped by 4833.48% to $400500.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $400500.0 (Q4 2025), $8118.0 (Q4 2024), and $42000.0 (Q1 2024), per Business Quant data.